Celldex Therapeutics Inc (CLDX)
NASDAQ:CLDX
Holding CLDX?
Track your performance easily

Celldex (CLDX) Income Statement

1,056 Followers

Celldex Income Statement

Last quarter (Q2 2024), Celldex's total revenue was $2.50M, an increase of 832.09% from the same quarter last year. In Q2, Celldex's net income was $-35.84M. See Celldex’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 8.30M$ 6.88M$ 2.36M$ 4.65M$ 7.42M$ 3.57M
Cost of Revenue
$ 300.00K$ 300.00K$ 100.00K$ 100.00K$ 200.00K$ 100.00K
Gross Profit
$ 8.30M$ 6.88M$ 2.36M$ 4.65M$ 7.42M$ 3.57M
Operating Expense
$ 171.59M$ 148.93M$ 109.45M$ 73.80M$ 56.99M$ 58.10M
Operating Income
$ -175.79M$ -154.54M$ -115.23M$ -71.24M$ -63.35M$ -55.03M
Net Non Operating Interest Income Expense
$ 25.57M$ 13.11M$ 2.91M$ 505.00K$ 2.41M$ 4.15M
Other Income Expense
$ -80.70M$ 613.00K$ -5.23M$ 2.10M$ 13.78M$ 506.00K
Pretax Income
$ -150.22M$ -141.43M$ -112.33M$ -70.74M$ -60.95M$ -50.88M
Tax Provision
$ -36.07M$ -36.07M$ -17.48M$ -227.00K$ -1.17M$ -13.87M
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -150.22M$ -141.43M$ -112.33M$ -70.51M$ -59.78M$ -50.88M
Basic EPS
$ -2.75$ -2.92$ -2.40$ -1.64--
Diluted EPS
$ -2.75$ -2.92$ -2.40$ -1.64$ -2.02$ -3.51
Basic Average Shares
$ 224.22K$ 48.45K$ 46.89K$ 42.87K$ 29.64K$ 14.51M
Diluted Average Shares
$ 224.22K$ 48.45K$ 46.89K$ 42.87K$ 29.64K$ 14.51M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 171.89M$ 148.93M$ 109.45M$ 73.90M$ 57.19M$ 58.20M
Net Income From Continuing And Discontinued Operation
$ -150.22M$ -141.43M$ -112.33M$ -70.51M$ -59.78M$ -50.88M
Normalized Income
$ -35.48M-----
Interest Expense
------
EBIT
$ -152.82M$ -142.04M$ -107.10M$ -69.15M$ -49.57M$ -50.88M
EBITDA
$ -146.41M$ -139.03M$ -104.20M$ -66.08M$ -45.64M$ -47.16M
Currency in USD

Celldex Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis